Komori
Nichirin (5184) · FactDecrease in R&D Expenses

Investment in Research and Development

First written in FY2016-Q2. 13 of 36 entries say "Advanced", first in FY2016-Q3. Latest entry: FY2026-H1.

36entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2016-Q3 – FY2018-Q3OtherFY2020-Q1 – FY2021-Q3OtherFY2023-Q1 – FY2025-H12016: 220162017: 420172018: 420182019: 320192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 45 companies write about · 18 as a headwind · 10 as a tailwind

26 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 45 companies compared. The sentences above are computed from all 45.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Decrease in R&D ExpensesAnnual report

    「The Group's total R&D spending for the six-month interim period was ¥635 million. There were no material changes in the status of the Group's R&D activities during the six-month interim period.」

    While stating that there were no material changes in R&D activities, the company reported that R&D expenses decreased from ¥660 million in the same period of the previous year to ¥635 million.
  2. FY2025AdvancedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥1,303 million (¥1,220 million in the previous consolidated fiscal year), and the company conducts R&D activities in Japan.」

    R&D expenses totaled ¥1,303 million, an increase from ¥1,220 million in the previous fiscal year.
  3. FY2025-H1Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the six-month interim period was ¥660 million. There were no material changes in the status of the Group's R&D activities during the six-month interim period.」

    While stating that there were no material changes in R&D activities, the company reported that R&D expenses increased from ¥586 million in the same period of the previous year to ¥660 million.
  4. FY2024Decrease in R&D ExpensesAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥1,220 million (¥1,248 million in the previous consolidated fiscal year), and the company conducts R&D activities in Japan.」

    R&D activities are continuing, but R&D expenses decreased from ¥1,248 million in the previous fiscal year to ¥1,220 million.
  5. FY2024-H1Decrease in R&D ExpensesAnnual report

    「The Group's total R&D spending for the six-month interim period was ¥586 million. There were no material changes in the status of the Group's R&D activities during the six-month interim period.」

    While stating that there were no material changes in R&D activities, the company reported that R&D expenses decreased from ¥612 million in the same period of the previous year to ¥586 million.
  6. FY2024-Q1Decrease in R&D ExpensesAnnual report

    「The Group's total R&D spending for the three months ended the first quarter was ¥286 million. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D spending decreased from ¥330 million in the same period of the previous year to ¥286 million.
  7. FY2023Decrease in R&D ExpensesAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥1,248 million (¥1,287 million in the previous consolidated fiscal year), and the company conducts R&D activities in Japan.」

    R&D activities are continuing, but total R&D expenses decreased from ¥1,287 million in the previous year to ¥1,248 million. The development and mass production of new products such as Teflon SUS hoses are progressing.
  8. FY2023-Q3Decrease in R&D ExpensesAnnual report

    「The Group's total R&D spending for the nine months ended the third quarter was ¥935 million.」

    R&D expenses decreased from ¥958 million in the same period of the previous year to ¥935 million. The company stated that there were no material changes in the status of its R&D activities.
  9. FY2023-Q2Decrease in R&D ExpensesAnnual report

    「The Group's total R&D spending for the six months ended the second quarter was ¥612 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D expenses decreased from ¥637 million in the same period of the previous year to ¥612 million.
  10. FY2023-Q1Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the three months ended the first quarter was ¥330 million. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D expenses increased from ¥312 million in the same period of the previous year to ¥330 million.
  11. FY2022AdvancedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥1,287 million (¥1,247 million in the previous consolidated fiscal year), and the company conducts R&D activities in Japan.」

    R&D expenses increased from ¥1,247 million in the previous fiscal year to ¥1,287 million.
  12. FY2022-Q3Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the nine months ended the third quarter was ¥958 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses increased from ¥923 million in the same period of the previous year to ¥958 million, while the company stated that there were no material changes in the status of its R&D activities.
  13. FY2022-Q2Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the six months ended the second quarter was ¥637 million.」

    R&D expenses increased from ¥595 million in the same period of the previous year to ¥637 million. Meanwhile, the company stated that there were no material changes in the status of its R&D activities.
  14. FY2022-Q1Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the three months ended the first quarter was ¥312 million. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D spending increased from ¥277 million in the same period of the previous year to ¥312 million.
  15. FY2021AdvancedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥1,247 million (¥1,093 million in the previous consolidated fiscal year), and the company conducts R&D activities in Japan.」

    R&D expenses increased from ¥1,093 million in the previous fiscal year to ¥1,247 million. Development and mass-production activities for the SLIM series, new IHX specifications and resin products are also taking concrete shape.
  16. FY2021-Q3Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the nine months ended the third quarter was ¥923 million.」

    R&D spending increased from ¥806 million in the same period of the previous year to ¥923 million. Meanwhile, the company stated that there were no material changes in the status of its R&D activities.
  17. FY2021-Q2Increase in R&D expensesAnnual report

    「The Group's total R&D spending for the six months ended the second quarter was ¥595 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D spending increased from ¥543 million in the same period of the previous year to ¥595 million.
  18. FY2021-Q1Decrease in R&D ExpensesAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥277 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」

    While stating that there were no material changes in R&D activities, the company reported that R&D spending decreased from ¥290 million in the same period of the previous year to ¥277 million.
  19. FY2020Decrease in R&D ExpensesAnnual report

    「Total research and development expenses for the fiscal year were ¥1,093 million (¥1,136 million in the previous fiscal year), and research and development activities are conducted in Japan.」

    Research and development activities continued, but total research and development expenses fell from ¥1,136 million in the previous year to ¥1,093 million.
  20. FY2020-Q3RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative third quarter was ¥806 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」

    It reports research and development expenses of ¥806 million and states that there were no material changes in the status of research and development activities.
  21. FY2020-Q2RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter was ¥543 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」

    It reports research and development expenditure of ¥543 million but states that there were no material changes in the status of those activities.
  22. FY2020-Q1RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥290 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」

    It reports research and development expenses of ¥290 million but states that there were no material changes in the status of research and development activities.
  23. FY2019AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥1,136 million (¥1,129 million in the previous fiscal year), and research and development activities are conducted in Japan.」

    Research and development expenses were ¥1,136 million, up from ¥1,129 million in the previous fiscal year. The development content, including IHX, new hose specifications, and products incorporating resin components, has also been specified in greater detail.
  24. FY2019-Q3RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative third quarter was ¥831 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」

    It reports research and development expenditure of ¥831 million but states that there were no material changes in the status of research and development activities.
  25. FY2019-Q2RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter was ¥537 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」

    It reports research and development expenditure of ¥537 million and states that there were no material changes in the status of those activities.
  26. FY2019-Q1RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥267 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」

    It reports research and development expenses of ¥267 million and states that there were no material changes in the status of research and development activities.
  27. FY2018-Q3AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative third quarter was ¥824 million.」

    Research and development expenditure was ¥824 million, up from ¥792 million in the same period of the previous year.
  28. FY2018-Q2AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter was ¥570 million.」

    Research and development expenditure was ¥570 million, up from ¥521 million in the same period of the previous year.
  29. FY2018-Q1AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥275 million.」

    Research and development expenditure was ¥275 million, up from ¥265 million in the same period of the previous year.
  30. FY2017AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥1,087 million (¥1,013 million in the previous fiscal year), and research and development activities are conducted in Japan.」

    Research and development expenses were ¥1,087 million, up from ¥1,013 million in the previous fiscal year.
  31. FY2017-Q3AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative third quarter was ¥792 million.」

    It reports research and development expenditure of ¥792 million for the cumulative third quarter.
  32. FY2017-Q2AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter was ¥521 million.」

    It reports research and development expenditure of ¥521 million for the cumulative second quarter.
  33. FY2017-Q1AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥265 million.」

    It reports research and development expenditure of ¥265 million for the cumulative first quarter.
  34. FY2016AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥1,013 million (¥980 million in the previous fiscal year), and research and development activities are conducted in Japan.」

    Annual research and development expenses were ¥1,013 million, up from ¥980 million in the previous year.
  35. FY2016-Q3AdvancedAnnual report

    「The Group's total research and development expenditure for the cumulative third quarter was ¥725 million.」

    Research and development expenditure was updated from ¥480 million for the cumulative second quarter to ¥725 million.
  36. FY2016-Q2First statedAnnual report

    「The Group's total research and development expenditure for the cumulative second quarter was ¥480 million.」

    It states that research and development expenditure for the cumulative quarter was ¥480 million.
Moved together

"Investment in property, plant and equipment" moved the same way as this thread, in the same document, in 10 of its 36 moves.

1099877★123456
  1. ★This thread
  2. 1Investment in property, plant and equipment10×
  3. 2Continuous Productivity Improvements and Cost Reduction9×
  4. 3Growth in Operating Profit and Profit Attributable to Owners of the Parent9×
  5. 4Deliveries to Overseas Customers and Product Sales Expansion8×
  6. 5Payment of Interim Dividends7×
  7. 6Expanding the European Business Base by Making the Spanish Business a Consolidated Subsidiary7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nichirin yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Investment in Research and Development | NICHIRIN CO.,LTD. (5184) | Komori